The LATAM women hypoactive sexual desire disorder treatment market accounted for $131 million in 2019, and is expected to reach $170 million by 2027, registering a CAGR of 3.8% from 2020 to 2027.
Report Code : A07587 | Pages : 145 | Category : Life Sciences
The global injection pen market was valued at $ 37899.00 million in 2021 and is projected to reach $80511.51 million by 2031, growing at a CAGR of 7.8% from 2022 to 2031.
Report Code : A07629 | Pages : 428 | Category : Life Sciences
The global surgical drains market was valued at $2.1 billion in 2020, and is projected to reach $3.1 billion by 2030, growing at a CAGR of 4.1% from 2021 to 2030.
Report Code : A07517 | Pages : 313 | Category : Life Sciences
The global stable isotope labeled compounds market was valued at $291.82 million in 2023, and is projected to reach $420.1 million by 2035, growing at a CAGR of 3.1% from 2024 to 2035.
Report Code : A07585 | Pages : 317 | Category : Life Sciences
The LATAM pain management drugs market was valued at $2,683.82 million in 2019, and is projected to reach $3,383.20 million by 2027, registering a CAGR of 3.5% from 2020 to 2027.
Report Code : A07588 | Pages : 235 | Category : Life Sciences
The global breast cancer liquid biopsy market size was valued at $87,641 thousand in 2019, and is projected to reach $357,051 thousand by 2027, registering a CAGR of 19.2% from 2019 to 2027.
Report Code : A07618 | Pages : 305 | Category : Life Sciences
The global electroceuticals market was valued at $19.8 billion in 2022, and is projected to reach $40.5 billion by 2032, growing at a CAGR of 7.4% from 2023 to 2032.
Report Code : A07649 | Pages : 257 | Category : Life Sciences
The global dental lasers market was valued at $364.1 million in 2022, and is projected to reach $634.1 million by 2032, growing at a CAGR of 5.7% from 2023 to 2032.
Report Code : A07651 | Pages : 250 | Category : Life Sciences
The global animal model market was valued at $1.9 billion in 2022, and is projected to reach $3.6 billion by 2032, growing at a CAGR of 6.6% from 2023 to 2032.
Report Code : A07946 | Pages : 295 | Category : Life Sciences
The global cancer stem cells market was valued at $1.1 billion in 2021 and is projected to reach $2.7 billion by 2031, growing at a CAGR of 10% from 2022 to 2031.
Report Code : A08105 | Pages : 200 | Category : Life Sciences
The global smart home healthcare market was valued at $4.81 billion in 2021, and is projected to reach $11.22 billion by 2031, growing at a CAGR of 8.8% from 2022 to 2031.
Report Code : A08117 | Pages : 303 | Category : Life Sciences
The global clinical decision support system market was valued at $5.3 billion in 2023, and is projected to reach $14.9 billion by 2033, growing at a CAGR of 10.9% from 2024 to 2033.
Report Code : A08190 | Pages : 280 | Category : Life Sciences
The global biohazard bags market was valued at $396.60 million in 2021, and is projected to reach $679.10 million by 2030, growing at a CAGR of 6.38% from 2022 to 2030.
Report Code : A07949 | Pages : 178 | Category : Life Sciences
The global bioprocess validation market size was valued at $265.15 million in 2019 and is projected to reach $410.80 million by 2027, registering a CAGR of 5.5% from 2020 to 2027.
Report Code : A07992 | Pages : 139 | Category : Life Sciences
The global extracorporeal membrane oxygenation market was valued at $527.5 million in 2023, and is projected to reach $952.2 million by 2035, growing at a CAGR of 5% from 2024 to 2035.
Report Code : A08108 | Pages : 403 | Category : Life Sciences
The global clinical risk grouping solutions market was valued at $0.4 billion in 2021 and is projected to reach $1.6 billion by 2031, growing at a CAGR of 14.6% from 2022 to 2031.
Report Code : A08191 | Pages : 290 | Category : Life Sciences
The global clinical workflow solutions market was valued at $9.6 billion in 2021, and is projected to reach $29.3 billion by 2031, growing at a CAGR of 11.8% from 2022 to 2031.
Report Code : A08193 | Pages : 326 | Category : Life Sciences
The global constipation treatment market was valued at $5.9 billion in 2022, and is projected to reach $10.1 billion by 2032, growing at a CAGR of 5.6% from 2023 to 2032.
Report Code : A08195 | Pages : 479 | Category : Life Sciences
The global digestive enzymes market was valued at $699.40 million in 2021, and is projected to reach $1.64 billion by 2031, growing at a CAGR of 8.7% from 2022 to 2031.
Report Code : A08198 | Pages : 178 | Category : Life Sciences
The global prosthetics market was valued at $1.6 billion in 2021, and is projected to reach $2.5 billion by 2031, growing at a CAGR of 4.5% from 2022 to 2031.
Report Code : A08292 | Pages : 220 | Category : Life Sciences
The global testosterone replacement therapy market was valued at $1.9 billion in 2022, and is projected to reach $2.9 billion by 2032, growing at a CAGR of 4.2% from 2023 to 2032.
Report Code : A08394 | Pages : 270 | Category : Life Sciences
The global OTC braces and supports market was valued at $649.71 million in 2019, and is estimated to reach $991.80 million by 2030, growing at a CAGR of 5.0% from 2021 to 2030.
Report Code : A08284 | Pages : 283 | Category : Life Sciences
The global real world evidence solutions market was valued at $1.4 billion in 2021, and is projected to reach $5 billion by 2031, growing at a CAGR of 13.7% from 2022 to 2031.
Report Code : A08294 | Pages : 377 | Category : Life Sciences
The global oligonucleotide synthesis market was valued at $5,197.50 million in 2020, and is projected to reach $26,099.90 million by 2030, registering a CAGR of 17.10% from 2021 to 2030.
Report Code : A08356 | Pages : 243 | Category : Life Sciences
The global medical batteries market was valued at $1.4 billion in 2022, and is projected to reach $2.4 billion by 2032, growing at a CAGR of 5.3% from 2023 to 2032.
Report Code : A08391 | Pages : 305 | Category : Life Sciences
